Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
20 participants
INTERVENTIONAL
2011-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The study design is a prospective, double blinded, randomised, controlled trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson's Disease (PD) Symptoms and Biomarkers (MCT-PD)
NCT04584346
Effect of a Lipidic and Proteic Controlled Diet on Parkinson's Disease
NCT02687698
Ketogenic Diet Interventions in Parkinson's Disease: Safeguarding the Gut Microbiome
NCT05469997
Caffeine as a Therapy for Parkinson's Disease
NCT01738178
Influence of Glucose on Metabolism and Clinical Symptoms of Patients With Parkinson's Disease
NCT05998772
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ketone ester drink Vs placebo drink
Ketone ester drink Vs placebo drink (cross over study - all patients will recieve both)
Ketone ester drink
Ketone drink - milligram per kilogram dose, consumed three times daily (at meal times)
Placebo (carbohydrate containing) drink
Placebo drink - containing carbohydrates, matched in calories to ketone, consumed three times daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ketone ester drink
Ketone drink - milligram per kilogram dose, consumed three times daily (at meal times)
Placebo (carbohydrate containing) drink
Placebo drink - containing carbohydrates, matched in calories to ketone, consumed three times daily
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age of onset of Parkinson's disease symptoms \> 40 years old
* Duration of symptoms over 2 years
Exclusion Criteria
* Active psychosis
* Deep brain stimulation or apomorphine infusion
* Severe motor fluctuations
* Significant metabolic or uncontrolled medical cormorbidity
42 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University of Oxford and the John Radcliffe Hospital, Oxford
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
John Radcliffe Hospital
Oxford, Oxfordshire, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
10/H0606/74
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.